EODData

MEMBERSHIP REGISTER LOG IN

NASDAQ, TRDA: Entrada Therapeutics Inc

18 Jun 26 15:59
LAST:

7.070

CHANGE:
 0.28		OPEN:
6.970		HIGH:
7.205		ASK:
0.000		VOLUME:
141.3K
CHG(%):
4.11		PREV:
6.810		LOW:
6.760		BID:
0.000		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
18 Jun 266.9907.2056.7607.090339.7K
17 Jun 266.5407.0606.5056.810201.1K
16 Jun 266.5306.6206.3506.500173.9K
15 Jun 266.5906.7206.3906.575192.4K
12 Jun 266.3106.5106.1906.460185.9K
11 Jun 265.9706.3905.7606.310339.8K
10 Jun 266.3406.5005.9505.970269.0K
09 Jun 266.3906.7106.1506.370175.7K
08 Jun 266.3806.4856.1306.260245.8K
05 Jun 266.9307.1406.3406.370195.0K

PROFILE

Name:Entrada Therapeutics Inc
About:Entrada Therapeutics, Inc., a clinical-stage biotechnology company, develops endosomal escape vehicle (EEV) therapeutics for the treatment of multiple neuromuscular diseases. The company's EEV platform develops products based on oligonucleotide, enzyme, and antibody-conjugated EEV peptides. Its therapeutic candidates, which include ENTR-601-44 that is in Phase 1 clinical trial for the treatment of Duchenne muscular dystrophy; and VX-670, which is in Phase 1/2 clinical trial for the treatment of myotonic dystrophy type 1. The company also offers ENTR-601-45, ENTR-601-50, and ENTR-601-51, which are in preclinical trial, for the treatment of Duchenne muscular dystrophy; and PTI-501, an intracellular thymidine phosphorylase enzyme replacement therapy for the treatment of mitochondrial neurogastrointestinal encephalomyopathy. It has strategic collaboration and license agreements with Vertex Pharmaceuticals Incorporated to research, develop, manufacture, and commercialize VX-670; and Pierrepont Therapeutics, Inc. to advance the development of PTI-501. The company was formerly known as CycloPorters, Inc. and changed its name to Entrada Therapeutics, Inc. in October 2017. Entrada Therapeutics, Inc. was incorporated in 2016 and is headquartered in Boston, Massachusetts.
Sector:Healthcare
Industry:Biotechnology
Address:One Design Center Place, Boston, MA, United States, 02210
Website:https://www.entradatx.com
CUSIP:29384C108
CIK:0001689375
ISIN:US29384C1080
FIGI:BBG00MTSMC16

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

  Download

FUNDAMENTALS

Trailing P/E:10.05 
Forward P/E:-3.99 
PEG Ratio:-0.06 
Price to Sales:3.33 
Price to Book:1.61 
Profit Margin:-0.92 
Operating Margin:-24.03 
Return on Assets:-0.12 
Return on Equity:-0.18 
EPS Ratio:-3.47 
Revenue:79.48M 
EBITDA:50.78M 
Shares:38.28M 
Market Cap:270.67M 

TECHNICAL INDICATORS

MA5:6.695.7%
MA10:6.479.2%
MA20:6.607.2%
MA50:9.4834.1%
MA100:10.7151.5%
MA200:9.4433.5%
STO9:90.69 
STO14:90.69 
RSI14:50.29
MTM14:0.18
ROC14:0.03 
ATR:0.46 
Week High:7.211.9%
Week Low:5.7622.7%
Month High:7.211.9%
Month Low:5.6333.5%
Year High:16.45132.7%
Year Low:4.9343.4%
Volatility:185.61